Medical News

RSS

Today's OpEds: Harkin, Coleman, Leavitt and others

Despite all the talk recently about how our nation has become divided and ungovernable, we have proved not only that we are governable, but also that we still have the capacity to act with boldness and vision (Sen. Tom Harkin, 4/6).

7 Apr 2010

At home, congressional Dems face voters on health bill, Rep. Issa investigating 'deals'

Before Congress left town for the spring recess, Speaker Nancy Pelosi urged rank-and-file Democrats to return home and tout the benefits of the landmark health care bill, Politico reports.

7 Apr 2010

Astrogenetix narrows in on MRSA virulence onboard space shuttle Discovery

Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.

6 Apr 2010

Changes coming to insurance plans

Kaiser Health News staff writer Julie Appleby sets out to clarify how the new health law might change consumers' current health insurance premiums and benefits.

6 Apr 2010

Three scientific posters featuring Zenvia to be presented at AAN Annual Meeting

AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.

6 Apr 2010

New web-based technology platform for late phase clinical research

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry.

6 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

Investment report on Keryx Biopharmaceuticals from BeaconEquity.com

BeaconEquity.com announces an investment report featuring Keryx Biopharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

6 Apr 2010

StockPreacher.com releases investment report on Repros Therapeutics

StockPreacher.com announces an investment report featuring Repros Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

6 Apr 2010

Src can be most promising targets for cancer therapy

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

6 Apr 2010

SANUWAVE Health announces completion of patient enrollment in dermaPACE Phase III clinical trial

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACE™ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACE™ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.

6 Apr 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and preliminary twelve-month periods ended December 31, 2009.

6 Apr 2010

USPTO issues patent for Taro Pharmaceutical Industries' T2007

Taro Pharmaceutical Industries Ltd. announced that the U.S. Patent and Trademark Office has issued United States Patent No. 7,683,071 covering T2007. The patent, entitled "Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid," is for one of a class of non-sedating barbiturate compounds currently in development by the Company.

6 Apr 2010

Policy makers and experts to discuss future challenges in respiratory diseases

This lunchtime seminar entitled "Research and Respiratory Medicine: Addressing future challenges for improved lung health" is being organised by the European Respiratory Society in the context of 2010 the Year of the Lung and under the patronage of Prof. Ioannis A. Tsoukalas MEP and Ms. Satu Hassi MEP.

6 Apr 2010

New head-mounted display system lets anesthesiologists focus on monitoring data during surgery

A new head-mounted display system lets anesthesiologists keep an eye on critical monitoring data during surgery—without having to turn their attention away from the patient, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

6 Apr 2010

Health care reform will have negative effect on cardiology patients, practices: American cardiologists

American cardiologists believe that recently passed health care reform will have a negative effect on both their cardiology patients and their practices, according to a new survey.

6 Apr 2010

Messenger substance plays significant role in viral diseases and reactions to infections

The connection with the blood circulatory system is a significant step in the development of cancer. Within the tissue where it is growing, the tumour develops an independent existence. With signal substances it entices white blood cells from the bone marrow into the tumour tissue.

6 Apr 2010

OICR invests $415,000 to develop radiolabelled insulin probe for early detection of breast cancer

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research today announced an investment of $415,000 towards the development of a radiolabelled insulin probe for the early detection of breast cancer.

6 Apr 2010

FamilyCord acquires assets of Vista Cord

FamilyCord, a subsidiary of California Cryobank, announced the recent asset acquisition of Vista Cord, a regional cord blood bank primarily servicing the southern US states. In conjunction with the FDA and cryogenic transport experts, FamilyCord has successfully relocated all cord blood units to their state-of-the-art facility in Los Angeles.

6 Apr 2010

DLVSC offers Zeltiq procedure to freeze away unwanted fat cells

Zeltiq™, an innovative technology that freezes away unwanted fat, is now available at Dermatology, Laser and Vein Specialists of the Carolinas – making DLVSC one of the first medical practices in the Southeast to offer this breakthrough in fat reduction.

6 Apr 2010